Back to HomeBeta

ICD-10 Coding for Hodgkin's Lymphoma in Remission(C81.0A, C81.1A, C81.9A)

Complete ICD-10-CM coding and documentation guide for Hodgkin's Lymphoma in Remission. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Hodgkin's Disease in RemissionHL in Remission

Related ICD-10 Code Ranges

Complete code families applicable to Hodgkin's Lymphoma in Remission

C81.0-C81.9Primary Range

Hodgkin's Lymphoma

This range includes all subtypes of Hodgkin's Lymphoma, including those in remission.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C81.0ANodular lymphocyte predominant Hodgkin's lymphoma, in remissionUse when the patient has nodular lymphocyte predominant HL in remission with ongoing surveillance.
  • Pathology-confirmed subtype
  • Documentation of remission status
  • Surveillance plan
C81.1ANodular sclerosis Hodgkin's lymphoma, in remissionUse when the patient has nodular sclerosis HL in remission confirmed by imaging.
  • PET/CT showing complete metabolic response
  • No B symptoms for ≥3 months
C81.9AUnspecified Hodgkin's lymphoma, in remissionUse when the subtype cannot be determined but remission is confirmed.
  • Documentation of remission status
  • Rationale for unspecified subtype

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for Hodgkin's lymphoma in remission

Essential facts and insights about Hodgkin's Lymphoma in Remission

The ICD-10 code for Hodgkin's lymphoma in remission is C81.0A for nodular lymphocyte predominant subtype.

Primary ICD-10-CM Codes for hodgkin's lymphoma in remission

Nodular lymphocyte predominant Hodgkin's lymphoma, in remission
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed remission status with surveillance plan

Applicable To

  • Nodular lymphocyte predominant HL in remission

Excludes

  • Active Hodgkin's lymphoma (C81.0)

Clinical Validation Requirements

  • Pathology-confirmed subtype
  • Documentation of remission status
  • Surveillance plan

Code-Specific Risks

  • Incorrectly using history codes instead of remission codes

Coding Notes

  • Ensure documentation specifies remission and subtype.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Nodular lymphocyte predominant Hodgkin's lymphoma

C81.0
Active disease versus remission status

Nodular sclerosis Hodgkin's lymphoma

C81.1
Active disease versus remission status

Unspecified Hodgkin's lymphoma

C81.9
Active disease versus remission status

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Hodgkin's Lymphoma in Remission to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C81.0A.

Impact

Clinical: Misrepresents patient's current health status., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation Strategy

Educate providers on remission coding., Implement EHR prompts for remission documentation.

Impact

Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records and data reporting.

Mitigation Strategy

Ensure documentation specifies remission status and use appropriate remission codes.

Impact

Using history codes instead of remission codes.

Mitigation Strategy

Regular audits and provider education.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Hodgkin's Lymphoma in Remission, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Hodgkin's Lymphoma in Remission

Use these documentation templates to ensure complete and accurate documentation for Hodgkin's Lymphoma in Remission. These templates include all required elements for proper coding and billing.

Oncology follow-up for HL in remission

Specialty: Oncology

Required Elements

  • Diagnosis
  • Treatment history
  • Remission status
  • Surveillance plan

Example Documentation

Diagnosis: Nodular sclerosis Hodgkin lymphoma in remission. Last chemotherapy: 03/2025. Remission confirmed by PET/CT on 06/2025. Surveillance plan: CT every 6 months.

Examples: Poor vs. Good Documentation

Poor Documentation Example
HL in remission.
Good Documentation Example
Nodular sclerosis HL in remission per PET/CT on 06/2025, no B symptoms for 3 months, surveillance CT scheduled.
Explanation
The good example provides specific remission confirmation and a surveillance plan.

Need help with ICD-10 coding for Hodgkin's Lymphoma in Remission? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more